COMP <GO>
IMAX vs HLMN // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Imax Corporation (NYSE) VS. Hillman Solutions Corp. (NASDAQ) • 15-METRIC TALLY: IMAX 6
— HLMN 5
■ METRIC PARITY
LAST: $51.34 (+1.62%) • MKT CAP: $2.82B
options-implied-move
—
LAST: $7.80 (+2.77%) • MKT CAP: $1.52B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMAX VS. HLMN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMAX | HLMN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 60.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 35.60% | 4.80% | +30.80 | IMAX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.2x | 18.9x | +10.30 | HLMN | /valuation <GO> |
| Free Cash Flow Yield | 4.22% | 6.93% | -2.71 | HLMN | /fcf-yield <GO> |
| Operating Margin | 20.50% | 7.30% | +13.20 | IMAX | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 2.60% | +5.90 | IMAX | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 5.40% | +11.10 | IMAX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.02 | 1.72 | +2.30 | IMAX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | HLMN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.2 | 66.6 | -19.40 | HLMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 67.8x | 35.0x | +32.80 | HLMN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.82B | $1.52B | $1.30B | IMAX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMAX REV | HLMN REV | IMAX GROSS % | HLMN GROSS % | IMAX FCF | HLMN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $410.2M | $1.55B | 60.0% | — | $118.9M | $105.2M |
| FY 2024 | $352.2M | $1.47B | 54.0% | — | $62.4M | $183.3M |
| FY 2023 | $374.8M | $1.48B | — | — | $58.6M | $238.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMAX // BETA —
HLMN // BETA —